ahlam1399
07-24-2015, 04:57 PM
Biogen slashes 2015 forecast as MS drug sales disappoint
(Reuters) - Sales of Biogen Inc's roster of multiple sclerosis ***** failed to meet analysts' expectation, prompting the company to slash its full-year profit and sales forecast.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654199/s/486707fd/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=0tGxPOolpNw:vojA59DIQ2o:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=0tGxPOolpNw:vojA59DIQ2o:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=0tGxPOolpNw:vojA59DIQ2o:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=0tGxPOolpNw:vojA59DIQ2o:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=0tGxPOolpNw:vojA59DIQ2o:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/0tGxPOolpNw
(Reuters) - Sales of Biogen Inc's roster of multiple sclerosis ***** failed to meet analysts' expectation, prompting the company to slash its full-year profit and sales forecast.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654199/s/486707fd/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/businessNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/businessNews?a=0tGxPOolpNw:vojA59DIQ2o:yIl2AUoC8zA ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=0tGxPOolpNw:vojA59DIQ2o:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/businessNews?a=0tGxPOolpNw:vojA59DIQ2o:F7zBnMyn0Lo ) http://feeds.feedburner.com/~ff/reuters/businessNews?i=0tGxPOolpNw:vojA59DIQ2o:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/businessNews?a=0tGxPOolpNw:vojA59DIQ2o:V_sGLiPBpWU )
http://feeds.feedburner.com/~r/reuters/businessNews/~4/0tGxPOolpNw